| 英文别名 |
(3S,8R,9S,10R,13S,14S)-17-Iodo-10,13-dimethyl-2,3,4,7,8,9,10,11,12,13,14,15-dodecahydro-1H-cyclopenta[a]phenanthren-3-ol;(3S,8R,9S,10R,13S,14S)-17-Iodo-10,13-dimethyl-2,3,4,7,8,9,10, 11,12,13,14,15-dodecahydro-1H-cyclopenta[a]phenanthren-3-...;17-Iodoandrosta-5,16-dien-3beta-ol;17-Iodo-androsta-5,16-diene-3β-ol;3β-hydroxy-17-iodo-androsta-5,16-diene;AK101607;AMX10149;ANW-62842;CTK8B9647;KB-207662;SureCN939291;DTXSID40454083;CS-M1865;DB-345656;3beta-hydroxy-17-iodo androsta-5,16-diene;AC-25765;AKOS016004244;(3S,8R,9S,10R,13S,14S)-17-iodo-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15-decahydro-1H-cyclopenta[a]phenanthren-3-ol;BCP12288;(3AS,3BR,7S,9AR,9BS,11AS)-1-IODO-9A,11A-DIMETHYL-3H,3AH,3BH,4H,6H,7H,8H,9H,9BH,10H,11H-CYCLOPENTA[A]PHENANTHREN-7-OL;(3beta)-17-Iodoandrosta-5,16-dien-3-ol;32138-69-5;A875694;CS-13060;P16973;17-iodo-androsta-5,16-dien-3beta-ol;C19H27IO;(3S,8R,9S,10R,13S,14S)-2,3,4,7,8,9,10,11,12,13,14,15-Dodecahydro-17-iodo-10,13-dimethyl-1H-cyclopenta[a]phenanthren-3-ol;DHZJEYGWSNDRGN-USOAJAOKSA-N;SCHEMBL939291;MFCD00199204 |
